Voltar
Artigo Revisado por pares
BIBTEX RIS

Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoida

1994; Wiley; Volume: 730; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1994.tb44251.x

ISSN

1749-6632

Autores

Raymond J. Jackson, Herman F. Staats, J Xu-Amano, Ichiro Takahashi, Hiroshi Kiyono, Michael E. Hudson, Richard M. Gilley, Steven N. Chatfield, Jerry R. McGhee,

Tópico(s)

vaccines and immunoinformatics approaches

Resumo

Annals of the New York Academy of SciencesVolume 730, Issue 1 p. 217-234 Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoida RAYMOND J. JACKSON, RAYMOND J. JACKSON Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorHERMAN F. STAATS, HERMAN F. STAATS Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorJIANGCHUN XU-AMANO, JIANGCHUN XU-AMANO Department of Immunology DNAX Research Institute 901 California Avenue Palo Alto, California 94304Search for more papers by this authorICHIRO TAKAHASHI, ICHIRO TAKAHASHI Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorHIROSHI KIYONO, HIROSHI KIYONO Department of Oral Biology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorMICHAEL E. HUDSON, MICHAEL E. HUDSON Vaccine and Oral Formulations Section Southern Research Institute Birmingham, Alabama 35255Search for more papers by this authorRICHARD M. GILLEY, RICHARD M. GILLEY Vaccine and Oral Formulations Section Southern Research Institute Birmingham, Alabama 35255Search for more papers by this authorSTEVEN N. CHATFIELD, STEVEN N. CHATFIELD Medeva Group Research Vaccine Research Unit Department of Biochemistry Imperial College of Science, Technology and Medicine London, SW7, UKSearch for more papers by this authorJERRY R. McGHEE, JERRY R. McGHEE Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this author RAYMOND J. JACKSON, RAYMOND J. JACKSON Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorHERMAN F. STAATS, HERMAN F. STAATS Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorJIANGCHUN XU-AMANO, JIANGCHUN XU-AMANO Department of Immunology DNAX Research Institute 901 California Avenue Palo Alto, California 94304Search for more papers by this authorICHIRO TAKAHASHI, ICHIRO TAKAHASHI Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorHIROSHI KIYONO, HIROSHI KIYONO Department of Oral Biology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this authorMICHAEL E. HUDSON, MICHAEL E. HUDSON Vaccine and Oral Formulations Section Southern Research Institute Birmingham, Alabama 35255Search for more papers by this authorRICHARD M. GILLEY, RICHARD M. GILLEY Vaccine and Oral Formulations Section Southern Research Institute Birmingham, Alabama 35255Search for more papers by this authorSTEVEN N. CHATFIELD, STEVEN N. CHATFIELD Medeva Group Research Vaccine Research Unit Department of Biochemistry Imperial College of Science, Technology and Medicine London, SW7, UKSearch for more papers by this authorJERRY R. McGHEE, JERRY R. McGHEE Department of Microbiology Immunobiology Vaccine Center and the Mucosal Immunization Research Group University of Alabama at Birmingham Medical Center Birmingham, Alabama 35294Search for more papers by this author First published: September 1994 https://doi.org/10.1111/j.1749-6632.1994.tb44251.xCitations: 15 a This work was supported by U.S. Public Health Service Contract AI 15128 for the UAB Mucosal Immunization Research Group. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Institute of Medicine. 1986. New Vaccine Development Establishing Priorities. Vol. 2. National Academy Press. Washington , DC . Google Scholar 2 Robbins, A., P. Freeman & K. R. Powell 1993. International childhood vaccine initiative. Pediatr. Infect. Dis. J. 12: 523–527. 10.1097/00006454-199306000-00012 CASPubMedWeb of Science®Google Scholar 3 McGhee, J. R. & H. Kiyono 1993. New perspectives in vaccine development: Mucosal immunity to infections. Infectious Agents and Disease,in press. PubMedWeb of Science®Google Scholar 4 Holmgren, J., C. Czerkinsky, N. Lycke & A. Svennerholm 1992. Mucosal immunity: Implications for vaccine development. Immunobiology 184: 157–159. 10.1016/S0171-2985(11)80473-0 CASPubMedWeb of Science®Google Scholar 5 Conley, M. E. & D. L. Delacroix 1987. Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense? Ann. Intern. Med. 106: 892–899. PubMedWeb of Science®Google Scholar 6 Mestecky, J. & J R. McGhee 1987. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40: 153–245. 10.1016/S0065-2776(08)60240-0 CASPubMedWeb of Science®Google Scholar 7 Craig, S. W. & J. J. Cebra 1974. Peyer's patches: An enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 134: 188–200. 10.1084/jem.134.1.188 PubMedWeb of Science®Google Scholar 8 Lebman, D. A., P. M. Griffin & J. J. Cebra 1987. Relationship between expression of IgA by Peyer's patch cells and functional IgA memory cells. J. Exp. Med. 166: 1405–1418. 10.1084/jem.166.5.1405 CASPubMedWeb of Science®Google Scholar 9 McGhee, J. R., J. Mestecky, C. O. Elson & H. Kiyono 1989. Regulation of IgA syynthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9: 175–199. 10.1007/BF00916814 CASPubMedWeb of Science®Google Scholar 10 Owen, R. L. & P. Nemanic 1978. Antigen processing structures of the mammalian intestinal tract: An SEM study of lymphoepithelial organs. Scanning Electron Microsc. 2: 367–378. Google Scholar 11 Neutra, M. R., T. L. Phillips, E. L. Mayer & D. J. Fishkind 1987. Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res. 247: 537–546. 10.1007/BF00215747 CASPubMedWeb of Science®Google Scholar 12 Pappo, J. & T. H. Ermak 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: A quantitative model for M cell uptake. Clin. Exp. Immunol. 76: 144–148. CASPubMedWeb of Science®Google Scholar 13 Gowans, J. L. & E. J. Knight 1964. The route of re-circulation of lymphocytes in the rat. Proc. R. Soc. Lond. B. Biol. Sci. 159: 257–282. 10.1098/rspb.1964.0001 CASPubMedWeb of Science®Google Scholar 14 McDermott, M. & J. Bienenstock 1979. Evidence for a common mucosal immunologic systemI. Migration of B immunoblasts into intestinal, respiratory and genital tissues.. J. Immunol. 122: 1892–1898. CASPubMedWeb of Science®Google Scholar 15 Mosmann, T. R. & R. L. Coffman 1989. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145–173. 10.1146/annurev.iy.07.040189.001045 CASPubMedWeb of Science®Google Scholar 16 Finkleman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann & W. E. Paul 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303–333. 10.1146/annurev.iy.08.040190.001511 PubMedWeb of Science®Google Scholar 17 Beagley K. W., J. H. Eldridge, H. Kiyono, M. P. Everson, W. J. Koopman, T. Honjo & J. R. McGhee 1988. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA positive Peyer's patch B cells. J. Immunol. 141: 2035–2042. CASPubMedWeb of Science®Google Scholar 18 Beagley, K. W., J. H. Eldridge, F. Lee, H. Kiyono, M. P. Everson, W. J. Koopman, T. Hirano, T. Kishimoto & J. R. McGhee 1989. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169: 2133–2148. CASPubMedWeb of Science®Google Scholar 19 Parronchi, P., M. De Carli, R. Manetti, C. Simonellie, S. Sampognaro, M. Piccinni, M. Donatella, E. Maggi, G. DelPrete & S. Romagnani 1992. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149: 2977–2983. CASPubMedWeb of Science®Google Scholar 20 Scott, P. 1991. IFN-γ modulates the early development of the Th1 and Th2 responses in murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149–3155. CASPubMedWeb of Science®Google Scholar 21 Weaver, C. T., C. M. Hawrylowicz & E. R. Uranue 1988. T helper cell subsets require the expression of distinct costimulatory signals by antigen presenting cells. Proc. Natl. Acad. Sci. USA 85: 8181–8185. 10.1073/pnas.85.21.8181 PubMedWeb of Science®Google Scholar 22 Spalding, D., S. Williamson, W. Koopman & J. R. McGhee 1984. Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J. Exp. Med. 160: 941–946. 10.1084/jem.160.3.941 CASPubMedWeb of Science®Google Scholar 23 Tomasi, T. B., Jr. 1980. Oral tolerance. Transplantation 29: 353–356. 10.1097/00007890-198005000-00001 PubMedWeb of Science®Google Scholar 24 Elson, C. O. & W. Ealding 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133: 2892–2897. CASPubMedWeb of Science®Google Scholar 25 Clements, J. D., N. M. Hartzog & F. L. Lyon 1988. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6: 269–277. 10.1016/0264-410X(88)90223-X CASPubMedWeb of Science®Google Scholar 26 Jackson, R. J., K. Fujihashi, J Xu-Amano, H. Kiyono, C. O. Elson & J. R. McGhee 1993. Optimizing oral vaccines: Induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as adjuvant. Infect. Immun. 61: 4272–4279. CASPubMedWeb of Science®Google Scholar 27 Xu-Amano, J., H. Kiyono, R. J. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai & J. R. McGhee 1993. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa-associated tissues. J. Exp. Med. 168: 1309–1320. 10.1084/jem.178.4.1309 Web of Science®Google Scholar 28 Xu-Amano, J. W., K. Aicher, T. Taguchi, H. Kiyono & J. R. McGhee 1992. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Intern. Immunol. 4: 433–445. PubMedGoogle Scholar 29 Wu, J. Y., C. H. Riggin, J. R. Seals, C. I. Murphy & M. J. Newman 1991. In vitro measurements of antigen-specific cell-mediated immune responses using recombinant HIV-1 proteins adsorbed to latex microspheres. J. Immunol. Methods 143: 1–9. 10.1016/0022-1759(91)90266-I CASWeb of Science®Google Scholar 30 Taguchi, T., J. R. McGhee, R. L. Coffman, K. W. Beagley, J. H. Eldridge, K. Takatsu & H. Kiyono 1990. Detection of individual mouse splenic T cells producing IFN-γ and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J. Immunol. Methods 128: 65–72. 10.1016/0022-1759(90)90464-7 CASPubMedWeb of Science®Google Scholar 31 Fujihashi, K., J. R. McGhee, K. W. Beagley & H. Kiyono 1993. Cytokine specific ELISPOT assay: Single cell analysis of IL-2, IL-4, and IL-6 producing cells. J. Immunol. Methods 160: 181–189. 10.1016/0022-1759(93)90176-8 CASPubMedWeb of Science®Google Scholar 32 Eldridge, J. H., C. J. Hammond, J. A. Meulkbroek, J. K. Stass, R. M. Gilley & T. R. Tice 1990. Controlled vaccine release in the gut-associated lymphoid tissuesI. Orally administered biodegradable microspheres target the Peyer's patches.. J. Controlled Release 11: 205–214. 10.1016/0168-3659(90)90133-E CASWeb of Science®Google Scholar 33 Dertzbaugh, M. T. & C. O. Elson 1991. Cholera toxin as a mucosal adjuvant. In Topics in Vaccine Adjuvant Research. D. R. Spriggs & W. C. Koff: 119–131. CRC Press. Boca Raton , FL . Google Scholar 34 Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater & N. F. Fairweather 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Biotechnology 10: 888–892. 10.1038/nbt0892-888 CASPubMedWeb of Science®Google Scholar Citing Literature Volume730, Issue1Microbial Pathogenesis and Immune ResponseSeptember 1994Pages 217-234 ReferencesRelatedInformation

Referência(s)